Shalby Ltd

SHALBY
NSE· Healthcare
₹164.58
+0.59 (+0.36%)
Updated 08:15 am IST
52W Low · ₹129.6952W High · ₹274.70
Near 52W Low
Market Cap
₹1864.85L Cr
Volume
50.1K
Prev Close
₹166.49
ISIN
INE597J01018

Orion Score

Fundamentals-based quality & risk · not a recommendation

46/100
Caution

Shalby Ltd scores 46/100 (Caution) on the Orion Score — weak business quality (42), moderate growth (62), weak balance-sheet safety (43) and rich valuation (39). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
42
Growth
62
Safety
43
Value
39

Full Orion analysis

Risk checks

  • Weak cash conversion (CFO 0.4x PAT) with modest returns

Forensic accounting

Piotroski F 3/9Altman Z Safe(5.65)Beneish M Elevated(-2.17)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

52/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Moderate
D/E 0.59x — manageable leverage
QUALITY
Low Quality
ROCE 5.8% — poor capital efficiency
MOMENTUM
Bearish
RSI 43.4 — weak momentum

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
53.81
ROCE
5.76%
ROE (1Y)
3.47%
D/E Ratio
0.59x
OPM
3.78%
TTM EPS
₹3.23
Dividend Yield
0.00%
Qtrly Sales
₹287.44 Cr
Qtrly Profit
₹18.32 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹287.44₹18.323.8%₹1.72
Q3 2026₹272.13₹1.764.6%₹0.12
Q2 2026₹285.43₹8.388.5%₹0.68
Q1 2026₹296.43₹8.928.4%₹0.71
Q4 2025₹264.89₹-11.021.7%₹-1.13

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2026₹1,141.43₹37.39₹169.546.4%
FY 2025₹1,086.95₹6.22₹160.26.2%
FY 2024₹928.22₹84.08₹194.8313.8%
FY 2023₹799.63₹67.7₹158.111.7%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
SHALBY ★₹1,865 Cr53.815.76%3.47%0.59x3.78%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹88,228 Cr25.6412.55%9.93%0.21x15.11%
ASTERDM₹71,372 Cr108.608.93%10.07%0.46x13.98%
ABBOTINDIA₹59,615 Cr38.4236.14%34.46%0.04x27.01%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹1,703.65₹1,607.53₹1,281.36₹1,193.54
Equity₹992.19₹1,000.37₹927.68₹876.32
Total Debt₹475.93₹377.87₹180.5₹174.07
Cash₹34.78₹27.18₹12.24₹55.55
Net Debt₹391.93₹286.77₹129.43₹99.46
Working Capital₹202.64₹228.98₹322.87₹276.41

Shareholding Pattern

Q1 FY2027

Promoter
76.11%
FII
0.07%
DII
0.06%
Public
23.76%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202776.11% ↑0.07% ↓0.06% ↓23.76% ↑
Q3 FY202674.33%4.47% ↓0.19%20.36% ↑
Q2 FY202674.33% ↑4.63% ↓0.19%20.18% ↑
Q1 FY202674.27%5.21% ↑0.19% ↑19.65% ↓
Q4 FY202574.27%4.54% ↓0.18% ↑20.33% ↑
Q3 FY202574.27% ↑4.65% ↓0.14% ↑20.26% ↑
Q2 FY202574.25%5.37% ↑0.09% ↑19.59% ↓
Q1 FY202574.25%5.35%0.06%19.65%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

2 mutual fund schemes

1
Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.03%

₹0 Cr

2
Motilal Oswal BSE 1000 Index Fund Direct GrowthMOTILAL_OSWAL

0.00%

₹0 Cr

Analyse SHALBY with Orion AI

Ask: "Is Shalby Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Shalby Ltd (SHALBY) Stock

Shalby Ltd is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE597J01018. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.